For healthcare professionals only

Research News

Over 15% of atrial fibrillation patients are not prescribed any antithrombotic agent for stroke prevention by GPs

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j4467 (Published 26 September 2017) Cite this as: BMJ 2017;358:j4467
  1. Ingrid Torjesen
  1. London

Antithrombotic treatment for stroke prevention in patients with non-valvular atrial fibrillation is improving, but nearly 20% still receive antiplatelet agents alone and over 15% no antithrombotic agents at all, a study published in BMJ Open has found.1

The study was based on five cross sectional analyses of general practice data in the UK Clinical Practice Research Datalink. Patients were included if they had a diagnosis of non-valvular atrial fibrillation and were eligible for anticoagulation under European Society …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription